4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-23-016789
EVP, COO acquired 3,666 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamothe Jeffrey G. EVP, COO | 2023-03-03 | Option exercise | +3,666 | 12,692 | D | ||
| Derivatives | |||||||
| Lamothe Jeffrey G. EVP, COO | 2023-03-03 | Option exercise · Restricted Stock Unit | −3,666 | 7,334 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2023-03-03 | Grant or award · Restricted Stock Unit | +16,500 | 16,500 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2023-03-03 | Grant or award · Stock Option (right to buy) | +16,500 | 16,500 | D | ||
Loading xslF345X03/doc4.xml…